HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Elite 50% OFF Act now – get top investing tools
00
Days
00
Hours
00
Mins
00
Sec
Register Now!
Market News Stocks News ETF News Crypto News

Cytokinetics, Incorporated

Contributing Author

Recent Articles by Cytokinetics, Incorporated

Nov-18
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) CYTK GlobeNewswire
Nov-17
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy CYTK GlobeNewswire
Nov-10
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 CYTK GlobeNewswire
Nov-05
Cytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update CYTK GlobeNewswire
Nov-04
Cytokinetics to Participate in November Investor Conferences CYTK GlobeNewswire
Oct-31
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 CYTK GlobeNewswire
Oct-22
Cytokinetics to Announce Third Quarter Results on November 5, 2025 CYTK GlobeNewswire
Oct-17
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) CYTK GlobeNewswire
Sep-29
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025 CYTK GlobeNewswire
Sep-24
Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program CYTK GlobeNewswire
Sep-23
Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum CYTK GlobeNewswire
Sep-18
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) CYTK GlobeNewswire
Sep-18
Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025 CYTK GlobeNewswire
Sep-16
Cytokinetics Announces Pricing of Upsized $650.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2027 Convertible Notes CYTK GlobeNewswire
Sep-16
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes CYTK GlobeNewswire
Aug-31
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025 CYTK GlobeNewswire
Aug-30
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine CYTK GlobeNewswire
Aug-27
Cytokinetics to Participate in September Investor Conferences CYTK GlobeNewswire
Aug-25
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 CYTK GlobeNewswire
Aug-20
Cytokinetics Names Jim Daly to Board of Directors CYTK GlobeNewswire
Aug-19
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CYTK GlobeNewswire
Aug-07
Cytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update CYTK GlobeNewswire
Jul-24
Cytokinetics to Announce Second Quarter Results On August 7, 2025 CYTK GlobeNewswire
Jul-18
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) CYTK GlobeNewswire
Jul-10
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025 CYTK GlobeNewswire
Jun-17
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CYTK GlobeNewswire
Jun-10
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program CYTK GlobeNewswire
May-29
Cytokinetics to Participate in the Jefferies Global Healthcare Conference CYTK GlobeNewswire
May-18
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress CYTK GlobeNewswire
May-16
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CYTK GlobeNewswire
May-15
Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology CYTK GlobeNewswire
May-13
Cytokinetics Announces Positive Topline Results From MAPLE-HCM CYTK GlobeNewswire
May-08
Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress CYTK GlobeNewswire
May-07
Cytokinetics to Hold Annual Meeting of Stockholders CYTK GlobeNewswire
May-06
Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update CYTK GlobeNewswire
May-01
Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy CYTK GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.